Cognitive impairment and sexual dysfunction move together in multiple sclerosis
Sexual health in multiple sclerosis is often treated as a separate conversation from cognition, gait, fatigue, or bladder dysfunction. This multicenter study argues for a more integrated view. In 318 people with multiple sclerosis seen in clinics in Mashhad and Gonabad, worse cognitive performance tracked with worse sexual dysfunction on a dedicated intimacy and sexuality questionnaire, and the relationship strengthened as disability increased.
The study used two established cognitive tools, the Paced Auditory Serial Addition Test and the Symbol Digit Modalities Test, alongside the Multiple Sclerosis Intimacy and Sexuality Questionnaire-19. That matters because sexual dysfunction in MS is not a single phenomenon. It can arise from direct neurologic injury, from the physical burden of disability, and from the psychological and relational strain that follows chronic disease. By separating primary, secondary, and tertiary sexual dysfunction, the analysis captured those layers instead of collapsing them into one blunt endpoint.
The strongest signal came from the overall MSISQ-19 score. Lower cognitive scores were associated with worse total sexual dysfunction, with the SDMT showing a correlation of r = -0.63 and the PASAT showing r = -0.24. In practical terms, patients with slower information processing and weaker divided attention also tended to report more difficulty with intimacy and sexual function. The association was not uniform across all subtypes of dysfunction, however. Primary sexual dysfunction showed no significant association with cognition, which suggests that the most direct neurophysiologic sexual symptoms may not map cleanly onto the cognitive measures used here.
Disability severity shaped the pattern
The Expanded Disability Status Scale emerged as a central modifier. EDSS was positively associated with sexual dysfunction, excluding primary dysfunction, and negatively associated with cognitive impairment. In plain clinical terms, as disability worsened, both cognition and sexual health tended to worsen together. The study’s GLMtree analysis sharpened that point by showing EDSS-dependent effects rather than a single linear pattern across the entire cohort.
At lower disability levels, PASAT was positively associated with secondary sexual dysfunction at EDSS 1-3 and with tertiary dysfunction at EDSS 3-5. By contrast, SDMT showed stronger negative associations with total, secondary, and tertiary sexual dysfunction at higher disability levels overall. These findings suggest that the nature of the cognitive-sexual relationship shifts as MS advances. Early in the disease, attention and working memory may be especially relevant to sexual functioning. At higher disability levels, processing speed may become a more powerful marker of the broader neurologic and functional burden that interferes with sexual health.
The pattern is biologically plausible. Sexual function in MS depends on intact neural pathways, but also on mobility, fatigue, pain, body image, mood, and relationship dynamics. Cognitive impairment can interfere with sexual desire and initiation, communication with a partner, and the ability to adapt to physical symptoms during intimacy. As disability increases, those pressures accumulate. A patient who is already struggling to walk, transfer, or manage sphincter symptoms is less likely to experience sexuality as a simple isolated domain of health.
Why the subtype split matters at the bedside
The lack of association with primary sexual dysfunction deserves attention. Primary dysfunction in MS is usually linked to direct demyelinating or axonal injury affecting the neural circuits of arousal and orgasm. Secondary dysfunction reflects physical consequences of the disease, while tertiary dysfunction reflects the psychological and social consequences. A cognitive measure is more likely to track the latter two categories than the first, and the data here fit that framework.
This distinction has direct implications for assessment. A clinician who asks only whether a patient has sexual dysfunction may miss the mechanism entirely. A patient with preserved primary sexual function may still have substantial secondary or tertiary problems driven by fatigue, reduced mobility, depression, embarrassment, or difficulty sustaining attention during intimacy. Conversely, a patient with prominent primary dysfunction may need a different workup and treatment strategy than one whose symptoms are mainly secondary or tertiary.
The study design was cross-sectional, so it cannot determine whether cognitive impairment worsens sexual dysfunction, whether sexual dysfunction contributes to poorer cognition through mood and stress pathways, or whether both are downstream expressions of more severe MS. Convenience sampling also limits how broadly the findings can be generalized. Still, the associations were strong enough to make a clinical point difficult to ignore: cognition and sexual health in MS are linked, and the link becomes more visible as disability rises.
What these findings change in routine MS care
For neurologists, rehabilitation clinicians, and sexual health providers, the practical message is straightforward. Sexual dysfunction in MS should not be handled as an afterthought or left to a separate referral pathway without context. Cognitive screening may help identify patients at higher risk for sexual problems, especially those with increasing EDSS scores. The reverse is also true: a complaint about sexual dysfunction may be an early signal that the broader neurologic burden is worsening, even before a patient frames it that way.
This study supports a more complete bedside conversation. Ask about sexual function with the same seriousness used for walking, bladder symptoms, and cognition. Then separate the complaint into its likely components: direct neurologic impairment, physical disability, and psychosocial strain. That approach is more likely to lead to a useful intervention than treating sexual dysfunction as a single symptom with a single cause.
The paper leaves one important question unanswered: which intervention, if any, can improve sexual function by targeting cognition directly in people with MS. The current data establish association, not reversibility. Future longitudinal work will need to determine whether stabilizing cognition, reducing disability progression, or treating mood and fatigue changes sexual outcomes in a measurable way.
- • PLOS One Study DOI: https://doi.org/10.1371/journal.pone.0361417